News Detail
New Delhi, 22 July 2021: A division bench of Delhi High Court has ordered that multinational pharmaceutical firm AstraZeneca and its Indian firm are not entitled for an interim relief in the form of an interim injunction against nine Indian pharmaceutical firms on alleged infring......
View Details
Source : Pharmabiz
Related News
- Complaint of the Police Inspector is legally invalid: Supreme Court (28-03-2024)
- DTAB recommends excipients causing high sensitivity to be mentioned on drug labels (28-03-2024)
- Antidepressants among 12 drugs fail quality test (28-03-2024)
- Joint team of CM flying squad, health department and police raids hospital (28-03-2024)
- Fake cancer drug case: Delhi Police speaks to victims (28-03-2024)
- Abiomed sees serious Impella recall linked to heart perforations, 49 deaths (27-03-2024)
- Sanofi, Cipla join hands to expand reach of CNS portfolio in India (27-03-2024)
- CCPA and ASCI join hands to strengthen advertising regulation in India (27-03-2024)
- DCC calls for strict implementation of revised Schedule M, state-level activities to address AMR (27-03-2024)
- US FDA reduces number of samples to retain for BA/BE testing (27-03-2024)